The Global Interventional Cardiology Devices Market registered a significant CAGR value of 9.00 percent between 2021-2026. Interventional cardiology is a branch of the cardiology department that is involved in using catheters for the treatment of heart diseases. The devices are widely used for treating cardiovascular diseases. The increasing tobacco consumption globally, increasing number obesity patients, and favourable reimbursements activities are the primary factors supporting the market growth. Rapid growth in global populations and the rising incidence of diabetes among all age groups are boosting the market growth. According to the facts published by the British Heart Foundation, it was estimated that more than 2.30 million people are suffering from CAD in the UK. About 170,000 people in the UK losing their lives every year due to heart and circulatory diseases. The growing adoption of minimally invasive surgeries and the introduction and adoption of advanced medical devices are also propelling the market growth. However, the availability of alternative medical treatments and product failures and recalls are hampering the global market growth.
Browse 155 Market Data
Tables and 117 Figures spread through 185 Pages and in-depth TOC on "Interventional
Cardiology Devices Market - Forecast to 2026"
By Product (Angioplasty Balloons, Angioplasty
Stents, Structural Heart Devices, Catheters, Plaque Modification Devices,
Hemodynamic Flow Alteration Devices, Other Devices), By Region (North America,
Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape,
Company Market Share Analysis & Competitor Analysis
Key Market Insights
·
The
global Interventional cardiology devices market will register a peak growth
rate and is expected to follow the trend between 2021-2026, owing to a high
prevalence of coronary artery diseases
·
According to the facts
published by the British Heart Foundation, it was estimated that more than 2.30
million people are suffering from CAD in the UK.
·
The hemodynamic flow
alteration devices segment dominated the global market and hold the largest
share between 2021-2026
·
Key players operating
in the market include are Medtronic, SCITECH, Boston Scientific Corporation,
Biosensors International Group, Abbott, Terumo Corporation, Edward Lifesciences
Corporation, B. Braun Melsungen, Cardinal Health, vascular, BIOTRONIK SE &
Co. KG, Becton, ENDOCOR GMBH, Dickinson, and Company, Insitu Technologies,
Inc., Meril Life Sciences Pvt. Ltd., Alvimedica, CardionovumGmbh, Smt, Medinol
Ltd., and Wellinq among others.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-interventional-cardiology-devices-market-2632
Product Outlook (Revenue, USD
Billion, 2020-2026)
·
Angioplasty Balloons
·
Angioplasty Stents
·
Structural Heart Devices
·
Catheters
·
Plaque Modification Devices
·
Hemodynamic Flow Alteration Devices
·
Other Devices
Regional Outlook (Revenue, USD Billion,
2020-2026)
North America
- The
U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest
of Europe
Asia Pacific
- China
- India
- Japan
- South
Korea
- Australia
- Rest
of APAC
Central & South America
- Brazil
- Argentina
- Rest
of CSA
Middle East & Africa
- Saudi
Arabia
- UAE
- Rest
of MEA
Contact:
Tracy Simon
Email
address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
